What Large Biologicals Companies Want From Startups

Lauren Milligan By Lauren Milligan|26 June 2026

What separates a promising biological startup from one that secures investment or a strategic partnership?

In this discussion, Sebastian Bachem, CEO of Accumont; José Nolasco, Head of Global R&D Bionutrition at Rovensa Next; Kevin Price, Head of Corporate Affairs at Certis Belchim; and Ignacio Moyano Córdoba, Vice President of Business Development for Latin America at DunhamTrimmer, share what larger companies look for when evaluating new technologies, including field validation, scalability, intellectual property, regulatory readiness, market fit, and demonstrated value for growers.

The panel also explains why strong science alone is no longer enough to stand out in today’s biologicals market.

New this year at Trade Summit, we are offering the biologicals speed pitch to U.S. ag retailers and roundtable discussions bringing synthetic and biological crop protection companies together. Join us at the Trade Summit on 5-6 August 2026 in Las Vegas.

Top Articles
Certis Belchim and Greenhas Group Expand Biostimulant Development Capability and Market Reach Through New Partnership

Lauren Milligan is Content Specialist for the Agribusiness Group, including AgriBusiness Global, CropLife, and Women in Ag Tech. Before joining Meister Media Worldwide in 2022, she received a bachelor’s degree in English from Kent State University in 2017 and has worked on newspapers local to Portage and Summit Counties in Ohio.  See all author stories here.